Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
CNS Oncology is Scopus-indexed (Q2, CiteScore 5), DOAJ. Published by Taylor and Francis Ltd..
Checked against the index lists dated .
ISSN 2045-0907Verify ISSN ↗2045-0915Verify ISSN ↗
Publisher: Taylor and Francis Ltd.
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Neurology (clinical) | 132 / 403 | 67th | Q2 |
| Neurology | 72 / 201 | 64th | Q2 |
Not listed in: Web of Science, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2012–present, best quartile Q2, CiteScore 5.
CNS Oncology is Q2 in Neurology (clinical) (rank 132 of 403) and Q2 in Neurology (rank 72 of 201), by CiteScore 2025.
CNS Oncology is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 5, quartile Q2, 67th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.992, quartile Q2, with an H-index of 38.
The publisher lists an article processing charge of about US$1,415 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
CNS Oncology is published by Taylor and Francis Ltd. Its print ISSN is 2045-0907 and its online ISSN is 2045-0915.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Yes — it is an open-access journal, listed in DOAJ.
CNS Oncology has an h-index of 43 and a 2-year mean of 3.31 citations per paper (OpenAlex). Its Scopus CiteScore is 5, quartile Q2. On 2-year citations it ranks #71 of 403 Scopus journals in Neurology (clinical).
CNS Oncology published 5 papers in 2025; its busiest recent year was 2017 with 34. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 63 research articles (2021–2026), authors are most often from United States (70.6%), France (4.8%) and India (4%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 2 retracted papers are recorded (4.9 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.